Table 2.
Laboratory and imaging features of the patients
TSH | fT4 | fT3 | ESR | CRP | TgAb | TPOAb | TRAb | Ultrasound and Doppler Findings | |
---|---|---|---|---|---|---|---|---|---|
1 | < 0,005 | 2,87 | 8,06 | 67 | 53,9 | Negative | Negative | Negative | Heterogeneous echotexture, with poorly defined regions of decreased echogenicity and pseudonodules |
2 | 0,015 | 2,93 | 6,84 | 81 | 193 | Negative | Negative | Negative | Ill-defined hypoechoic areas |
3 | 0,01 | 2,36 | 5,18 | 89 | 88,9 | 142 | Negative | Negative | Bilateral inflammation and hipovascularity, multiple lymphadenopathy |
4 | < 0,005 | 3,74 | 9,55 | 72 | 38,4 | Negative | Negative | Negative | Hypoechoic and heterogeneous areas with blurred margins |
5 | 0,01 | 2,59 | 4,62 | 82 | 78 | 307 | Negative | Negative | No significant alteration in ultrasonography, reduced 99mTc-perthecnetate uptake |
6 | 0,018 | 0,942 | 6,63 | 79 | 27 | > 4000 | > 4000 | > 30 | Bilateral enlarged thyroid gland, irregularly demarcated hypoechoic areas, decreased vascularity |
7 | < 0,005 | 2,04 | 5,11 | 89 | 34 | 222 | Negative | Negative | Hypoechoic and heterogeneous areas with blurred margins, poorly vascularization |
8 | < 0,005 | 3,05 | 6,59 | 51 | 51,8 | 542 | Negative | Negative | Inflammation and pseudonodularity |
9 | 0,07 | 4,29 | 11 | 33 | 43,3 | Negative | Negative | Negative | Heterogeneous gland with bilateral patchy ill-defined hypoechoic areas |
10 | 0,01 | 2,32 | 4,22 | 83 | 109 | Negative | Negative | Negative | Reduction in gland size, but bilateral inflammation |
11 | 0,024 | 4,27 | 9,03 | 79 | 125,4 | Negative | Negative | Negative | Multiple diffuse hypoechoic areas, decreased vascularity |
TSH thyroid stimulating hormone.( 0,27–4,2 uIU/ml) fT4 free thyroxine. (0,93–1,70 ng/dL) fT3 free triiodothyronine. (2,3–4,5 pg/mL) ESR erythrocyte sedimentation rate (0–20 mm/h). C-reactive Protein (0–5 mg/L) TgAb Anti-thyroglobulin antibodies (0–115 IU/mL) TPOAb Thyroid peroxidase antibodies (0–34 IU/mL) TRAb TSH receptor autoantibodies. (0–1,5 U/L)